The Net Margin of Kiniksa Pharmaceuticals Ltd (KNSA) is -10.21%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | -10.21% |
| 2023-12-31 | 5.21% |
| 2022-12-31 | 83.28% |
| 2021-12-31 | -409.72% |
| 2020-12-31 | -409.72% |